Literature DB >> 29371164

Anti-inflammatory effect of avenanthramides via NF-κB pathways in C2C12 skeletal muscle cells.

Chounghun Kang1, Woo Shik Shin2, Dongwook Yeo3, Wonchung Lim4, Tianou Zhang3, Li Li Ji5.   

Abstract

Avenanthramides (Avns), the polyphenol compounds found only in oats, have been shown to exhibit anti-inflammatory effects mainly by inhibiting nuclear factor (NF)-κB activation in select cell lines. However, the molecular mechanism by which Avns regulate the NF-κB pathway is still unclear. The purpose of this study was to investigate (1) the molecular mechanism by which three main fractions of Avns (AvnA, AvnB and AvnC) interact with IκB Kinase β (IKKβ); and (2) whether this interaction results in reduced inflammatory responses in skeletal muscle cells. The protein-ligand docking and molecular dynamics simulation studies suggest that Avns acted as an allosteric inhibitor for modulating IKKβ's affinity for the NF-κB complex. Thus, Avns reduced IKKβ kinase activity in response to tert-butyl hydroperoxide (tBHP) stimulation and attenuated tBHP-induced TNFα and IL-1β mRNA expression. Furthermore, the three-fold increases in cyclooxygenase-2 (COX-2) protein and luciferase activity with tBHP treatment were reduced by 50% with Avns (P < .01), along with decreased prostaglandin E2 levels (P < .01). These data indicate that Avns are potent inhibitors of NFκB-mediated inflammatory response due to the downregulation of IKKβ activity in C2C12 cells.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Avenanthramides; Inflammation; NF-κB; Skeletal muscle

Mesh:

Substances:

Year:  2018        PMID: 29371164     DOI: 10.1016/j.freeradbiomed.2018.01.020

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  9 in total

Review 1.  Cellular mechanism of immobilization-induced muscle atrophy: A mini review.

Authors:  Li Li Ji; Dongwook Yeo
Journal:  Sports Med Health Sci       Date:  2019-09-10

2.  Data on the mode of binding between avenanthramides and IKKβ domains in a docking model.

Authors:  Chounghun Kang; Woo Shik Shin; Dongwook Yeo; Wonchung Lim; Li Li Ji
Journal:  Data Brief       Date:  2018-02-06

3.  Avenanthramide supplementation reduces eccentric exercise-induced inflammation in young men and women.

Authors:  Tianou Zhang; Tong Zhao; Yuzi Zhang; Tao Liu; Gilles Gagnon; Jacqueline Ebrahim; Jodee Johnson; Yi-Fang Chu; Li Li Ji
Journal:  J Int Soc Sports Nutr       Date:  2020-07-25       Impact factor: 5.150

4.  Avenanthramides attenuate inflammation and atrophy in muscle cells.

Authors:  Dongwook Yeo; Chounghun Kang; Tianou Zhang; Li Li Ji
Journal:  J Sport Health Sci       Date:  2018-08-24       Impact factor: 7.179

Review 5.  Mitochondrial dysregulation and muscle disuse atrophy.

Authors:  Li Li Ji; Dongwook Yeo
Journal:  F1000Res       Date:  2019-09-11

6.  Phytochemical‑rich herbal formula ATG‑125 protects against sucrose‑induced gastrocnemius muscle atrophy by rescuing Akt signaling and improving mitochondrial dysfunction in young adult mice.

Authors:  Ching-Chuan Yeh; Hsuan-Miao Liu; Ming-Chung Lee; Yann-Lii Leu; Wei-Han Chiang; Hen-Hong Chang; Tzung-Yan Lee
Journal:  Mol Med Rep       Date:  2021-12-16       Impact factor: 2.952

7.  Avenanthramide C as a novel candidate to alleviate osteoarthritic pathogenesis.

Authors:  Thanh-Tam Tran; Won-Hyun Song; Gyuseok Lee; Hyung Seok Kim; Daeho Park; Yun Hyun Huh; Je-Hwang Ryu
Journal:  BMB Rep       Date:  2021-10       Impact factor: 4.778

Review 8.  Redox signaling at the crossroads of human health and disease.

Authors:  Jing Zuo; Zhe Zhang; Maochao Luo; Li Zhou; Edouard C Nice; Wei Zhang; Chuang Wang; Canhua Huang
Journal:  MedComm (2020)       Date:  2022-03-31

9.  Avenanthramide C suppresses hypoxia-induced cyclooxygenase-2 expression through sirtuin1 activation in non-small-cell lung cancer cells.

Authors:  Wonchung Lim; Chounghun Kang
Journal:  Anim Cells Syst (Seoul)       Date:  2020-04-02       Impact factor: 1.815

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.